Ahmed Zayed Obeidat, MD, PhD
- Neuroscience Institute – Specialty Clinics
- 900 N. 92nd St.
- Milwaukee, WI 53226
New & Established Patients Call
The key to success is teamwork. We will work together with you and your loved ones to fight MS and other neuroimmunological diseases in a personalized and comprehensive approach to best fit your needs and expectations. Remember, you are the center of our care and persistence is the key to success!
Diseases and Conditions
- Multiple Sclerosis (MS)
- Neuromyelitis Optica (NMO)
- Autoimmune Diseases of the Central Nervous System
- Autoimmune Encephalitis
- Anti-MOG Disease
Treatments and Services
- Oral/injectable/infused and Symptomatic Therapies for Multiple Sclerosis
- Virtual Visit
Patients Ages Seen
- Froedtert Hospital – Milwaukee
Neuroscience Institute – Specialty Clinics
- 900 N. 92nd St.
- Milwaukee, WI 53226
- (414) 805-5400
- Get Directions
Dr. Obeidat works with adults in diagnosing, treating and managing Multiple Sclerosis and Immune Disorders of the Central Nervous System. He received his medical degree with honors from the Jordan University of Science and Technology in 2008. He then joined the graduate program in neuroscience and physiology at Wright State University (WSU) in Dayton, Ohio where he received a PhD in Neuroscience and Physiology in 2013. He completed his neurology residency at the University of Cincinnati in 2017 as well as fellowship training in Demyelinating Diseases and Neuroimmunology, also from the University of Cincinnati, in 2018. Dr. Obeidat is an advocate for medical humanities and believes in the power of patient stories in shaping a successful, and a long-lasting patient-doctor relationship. In his free time, he enjoys reading and writing personal reflections and narrative medicine in its various forms.
Education and Training
Doctor of Medicine - Jordan University of Science and Technology - Irbid (2008)
Doctor of Philosophy in Biomedical Sciences (Neuroscience and Physiology) - Wright State University - Dayton, OH (2013)
Fellowship in Neuroimmunology and Multiple Sclerosis - University of Cincinnati - Cincinnati, OH (2017-2018)
Residency in Neurology - University of Cincinnati - Cincinnati, OH (2014-2017)
Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report.
(Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM.) Brain Behav Immun Health. 2023 Feb;27:100570 PMID: 36578920 PMCID: PMC9791578 12/30/2022
Opinion: The role of the registered dietitian nutritionist in multiple sclerosis care in the United States.
(Titcomb TJ, Bostick M, Obeidat AZ.) Front Neurol. 2023;14:1068358 PMID: 36846127 PMCID: PMC9947712 02/28/2023
A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
(Burtchell J, Clemmons D, Clemmons J, Sabutis T, Rosenberg A, Graves J, Sweeney ML, Kramer J, Ziehn M, Brown B, Weiss JL, Obeidat AZ.) Neurol Ther. 2022 Sep;11(3):955-979 PMID: 35608740 PMCID: PMC9127487 05/25/2022
Visual oscillation effects on dynamic balance control in people with multiple sclerosis.
(Riem L, Beardsley SA, Obeidat AZ, Schmit BD.) J Neuroeng Rehabil. 2022 Aug 17;19(1):90 PMID: 35978431 PMCID: PMC9382748 SCOPUS ID: 2-s2.0-85136056967 08/18/2022
Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis.
(Porwal MH, Patel D, Maynard M, Obeidat AZ.) Mult Scler Relat Disord. 2022 Jul;63:103832 PMID: 35512502 SCOPUS ID: 2-s2.0-85129551192 05/06/2022
Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies.
(Porwal MH, Obeidat AZ.) J Cent Nerv Syst Dis. 2022;14:11795735221127131 PMID: 36200126 PMCID: PMC9527983 10/07/2022
Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies.
(Porwal MH, Salter A, Patel D, Obeidat AZ.) J Cent Nerv Syst Dis. 2022;14:11795735221109674 PMID: 35769950 PMCID: PMC9234852 07/01/2022
Clinical Reasoning: A 42-Year-Old Woman With Mysterious Monocytic Meningitis.
(Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ.) Neurology. 2021 Aug 31;97(9):449-454 PMID: 33947775 SCOPUS ID: 2-s2.0-85116959005 05/06/2021
Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.
(Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE.) Neurol Clin Pract. 2021 Aug;11(4):352-357 PMID: 34484933 PMCID: PMC8382436 09/07/2021
Peppering the pons: CLIPPERS or myelin oligodendrocyte glycoprotein associated disease?
(Obeidat AZ, Block AN, Hooshmand SI.) Mult Scler Relat Disord. 2021 Jun;51:102874 PMID: 33714127 SCOPUS ID: 2-s2.0-85102657644 03/14/2021
A national telemedicine program in the Kingdom of Jordan - Editorial.
(Obeidat AZ, El-Salem K.) Ann Med Surg (Lond). 2021 Feb;62:145-149 PMID: 33520212 PMCID: PMC7820302 02/02/2021
A national telemedicine program in the Kingdom of Jordan – Editorial
(Obeidat AZ, El-Salem K.) Annals of Medicine and Surgery. February 2021;62:145-149 SCOPUS ID: 2-s2.0-85099623573 02/01/2021